Preclinical studies on toxicity, antitumour activity and pharmacokinetics of cisplatin and three recently developed derivatives.

No abstract is available for this paper.

• Publication year

  1984

• Venue

  European Journal of Cancer and Clinical Oncology

• Publication date

  1984-08-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0277-5379(84)90112-3PMID 6381064
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II

  2004cited by this paper
• Pharmacokinetics of cis-dichloro-trans-dihydroxy-bis-isopropylamine platinum IV (CHIP) in patients with advanced cancer

  2004cited by this paper
• Studies on the pharmacokinetics and metabolism of cis-dichloro-trans-dihydroxy-bis-isopropylamine platinum(IV) in the dog.

  1982cited by this paper
• Comparison of the iv and ip routes of administration of cisplatin in dogs.

  1981cited by this paper
• MORPHOLOGICAL MANIFESTATIONS OF CISPLATIN ANALOGS IN RATS: AN ULTRASTRUCTURAL STUDY

  1980cited by this paper
• The fifth Myron Karon Memorial Lecture. The cure of cancer by chemotherapy - reflections on how it happened.

  1980cited by this paper
• Parmacokinetic evidence for an enterohepatic circulation in a patient treated with cis dichloro diammine platinum II)

  1980cited by this paper
• Pharmacokinetic evidence for an enterohepatic circulation in a patient treated with cis-dichlorodiammineplatinum (II).

  1980cited by this paper
• ANTITUMOR ACTIVITY OF PLATINUM ANALOGS

  1980cited by this paper
• CISPLATIN NEPHROTOXICITY: THE EFFECT OF DOSE, SCHEDULE, AND HYDRATION SCHEME

  1980cited by this paper
• ANTITUMOR, TOXIC AND BIOCHEMICAL PROPERTIES OF CISPLATIN AND EIGHT OTHER PLATINUM COMPLEXES

  1980cited by this paper
• ANTITUMOR ACTIVITY OF CISPLATIN ANALOGS

  1980cited by this paper
• Structure-activity relationships of the antitumor platinum coordination complexes.

  1979cited by this paper
• Rationale for development of platinum analogs.

  1979cited by this paper
• Toxic effects of cis-dichlorodiammineplatinum(II) in man.

  1979cited by this paper
• Pharmacokinetic study of cis-dichlorodiammineplatinum(II) (DDP) in the beagle dog: thermodynamic and kinetic behavior of DDP in a biologic millieu.

  1979cited by this paper
• The pharmacokinetics of Cis-diamminodichloro-platinum (II) in animals and man : relation to treatment scheduling

  1978cited by this paper
• Improvement of Cis‐dichlorodiammineplatinum (NSC 119875): Therapeutic index in an animal model

  1977cited by this paper
• Distribution and disposition of platinum following intravenous administration of cis-diamminedichloroplatinum(II) (NSC 119875) to dogs.

  1976cited by this paper
• Comparative nephrotoxicity of platinum cancer chemotherapeutic agents.

  1976cited by this paper
• Biologic activity of two derivatives and six possible metabolites of cyclophosphamide (NSC-26271).

  1976cited by this paper
• Diaminodichloroplatinum: A phase I study showing responses in testicular and other tumors

  1974cited by this paper
• A direct measurement of the radiation sensitivity of normal mouse bone marrow cells.

  1961cited by this paper

• 2-Pyrocatechuic Acid Attenuates Carboplatin Induced Hematological Toxicities in Wistar Rats

  2022cites this paper
• Effective salvage therapy for high‐risk relapsed or refractory acute myeloid leukaemia with cisplatin in combination with high‐dose cytarabine and etoposide

  2014cites this paper
• The Efficacy of Recombinant Human Erythropoietin in Treatment Chemotherapy Induced Anemia in Children Diagnosed with a Solid Cancer

  2014cites this paper
• Antitumor and chemosensitizing action of dichloroacetate implicates modulation of tumor microenvironment: a role of reorganized glucose metabolism, cell survival regulation and macrophage differentiation.

  2013cites this paper
• metastases Validation of an orthotopic model of human lung cancer with regional and systemic

  2013cites this paper
• Antitumor activity of lobaplatin alone or in combination with antitubulin agents in non-small-cell lung cancer

  2012cites this paper
• EORTC-related new drug discovery and development activities: role of the Pharmacology and Molecular Mechanisms Group

  2012cites this paper
• Nickel, Ruthenium, Rhodium, Palladium, Osmium, and Platinum

  2012cites this paper
• DESIGN OF CONTROLLED AND TARGETED THERMAL SENSITIZER FOR ENHANCING RADIOFREQUENCY ABLATION

  2010cites this paper
• Cytotoxicity and cellular accumulation of a new cis-diammineplatinum (II) complex containing procaine in murine L1210 cells sensitive and resistant to cis-diamminedichloroplatinum (II)

  2009cites this paper
• Squalene selectively protects mouse bone marrow progenitors against cisplatin and carboplatin-induced cytotoxicity in vivo without protecting tumor growth.

  2008cites this paper
• Recombinant human erythropoietin in pediatric oncology

  2008cites this paper
• Effect of Intratumoral Injection of Carboplatin Combined with Pluronic P85 or L61 on Experimental Colorectal Carcinoma in Rats

  2007cites this paper
• Metastatic osteosarcoma

  2006cites this paper
• [‘3N]CisplatinPET to Assess Pharmacokinetics of Intra-ArterialVersus Intravenous Chemotherapy for Malignant Brain Tumors

  2006cites this paper
• Synthesis and in vitro cytotoxicity of novel hydrophilic chiral 2-alkoxy-1,4-butanediamine platinum (II) complexes.

  2005cites this paper
• A strategy for the development of two clinically active cisplatin analogs: CBDCA and CHIP

  2004cites this paper
• Iron- and ascorbic acid-induced lipid peroxidation in renal microsomes isolated from rats treated with platinum compounds

  2004cites this paper
• Resistance and cross-resistance of the IgM immunocytoma in the LOU/M Wsl rat for cisplatin, carboplatin, and iproplatin

  2004cites this paper
• Pentetration of carboplatin and cisplatin into rat peritoneal tumor nodules after intraperitoneal chemotherapy

  2004cites this paper
• Comparison of intestinal toxic effects of platinum complexes: cisplatin (CDDP), carboplatin (CBDCA), and iproplatin (CHIP)

  2004cites this paper
• Intra-arterial administration of carboplatin and the blood brain barrier permeabilizing agent, RMP-7: A toxicologic evaluation in swine

  2004cites this paper
• Carboplatin (CBDCA), iproplatin (CHIP), and high dose cisplatin in hypertonic saline evaluated for tubular nephrotoxicity

  2004cites this paper
• Etoposide, carboplatin, cyclophosphamide and vincristine in previously untreated patients with small-cell lung cancer

  2004cites this paper
• Comparative nephrotoxicity of carboplatin and cisplatin in combination with tobramycin

  2004cites this paper
• Characterization of novel nitroplatinum(iv) complexes for the treatment of cancer

  2004cites this paper
• Metabolism of Cisplatin to a nephrotoxin in proximal tubule cells.

  2003cites this paper
• REDUCTION IN TRANSFUSION REQUIREMENTS WITH EARLY EPOETIN ALFA TREATMENT IN PEDIATRIC PATIENTS WITH SOLID TUMORS: A Case-Control Study

  2002cites this paper
• Nephrotoxicity of heptaplatin: a randomized comparison with cisplatin in advanced gastric cancer

  2002cites this paper
• Early epoetin alfa treatment in children with solid tumors.

  2002cites this paper
• Validation of an orthotopic model of human lung cancer with regional and systemic metastases.

  2001cites this paper
• In vitro efficacy of chemotherapeutics as determined by 50% inhibitory concentrations in cell cultures of mammary gland tumors obtained from dogs.

  2001cites this paper
• Comparison of in vitro growth-inhibitory activity of carboplatin and cisplatin on leukemic cells and hematopoietic progenitors: the myelosuppressive activity of carboplatin may be greater than its antileukemic effect.

  2000cites this paper
• Recombinant human erythropoietin treatment for chemotherapy-related anemia in children.

  1999cites this paper
• Colony-promoting activity in mice kidneys with phenylhydrazine hemolytic anemia.

  1999cites this paper
• Monitoring local disposition kinetics of carboplatin in vivo after subcutaneous injection in rats by means of 195Pt NMR.

  1998cites this paper
• Last Supper for Mosquitoes

  1998cites this paper
• Future Prospects for Stealth Liposomes in Cancer Therapy

  1997cites this paper
• Potentiation of anticancer effects of microencapsulated carboplatin by hydroxypropyl α-cyclodextrin

  1996cites this paper
• Intravenous RMP-7 selectively increases uptake of carboplatin into rat brain tumors.

  1996cites this paper
• Computer recycling takes hold.

  1995cites this paper
• A model for chemosentivity testing using in vitro MTT assay on a human squamous carcinoma tongue cell line

  1994cites this paper
• Synthesis and antitumor activity of a series of [2-substituted-4,5-bis(aminomethyl)-1,3-dioxolane]platinum(II) complexes.

  1994cites this paper
• Comparative nephrotoxicity of a novel platinum compound, cisplatin, and carboplatin in male Wistar rats.

  1994cites this paper
• Dissimilar alterations of sodium-coupled uptake by platinum-coordination complexes in renal proximal tubular cells in primary culture.

  1994cites this paper
• Stability and compatibility of cisplatin and carboplatin with PVC infusion bags

  1994cites this paper
• Synthesis of carbon‐14 labelled cis‐malonato [(4R,5R)‐4,5‐bis(aminomethyl)‐2‐isopropyl‐1,3‐dioxolane] platinum(II) (ski 2053R)

  1994cites this paper
• The influence of platinum drugs on the radiation response of rat kidneys.

  1994cites this paper
• The change of serum erythropoietin level in patients with head and neck cancer

  1993cites this paper
• Nephrotoxicity and hydration management for cisplatin, carboplatin, and ormaplatin.

  1993cites this paper
• Recombinant human erythropoietin for the treatment of chronic anemia in multiple myeloma and squamous cell carcinoma

  1993cites this paper
• Combined chemo-radiotherapy with carboplatin, 5-fluorouracil and folinic acid for cancer of the urinary bladder: acute and late side effects.

  1993cites this paper
• Antitumor activity of platinum analogs against human lung cancer cell lines and tumor specimens.

  1993cites this paper
• A phase II trial of carboplatin in patients with advanced APUD tumors

  1993cites this paper
• Comparative study of cisplatin and carboplatin on pharmacokinetics, nephrotoxicity and effect on renal nuclear DNA synthesis in rats.

  1992cites this paper
• Antitumor Activity and Cellular Accumulation of a New Platinum Complex, (—)‐(R)‐2‐Aminomethylpyrrolidine(1,l‐cyclobutanedicarboxylato)platinum(II) Monohydrate, in Cisplatin‐sensitive and ‐resistant Murine P388 Leukemia Cells

  1992cites this paper
• Antitumor effects of three platinum complexes, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)-platinum (II) monohydrate (DWA2114R), cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) (CBDCA) and cis-diamminedichloroplatinum(II) (CDDP), in mice.

  1992cites this paper
• Quantitative ultrastructural effects of cisplatin (Platinol), carboplatin (JM8), and iproplatin (JM9) on neurons of freshwater snail Lymnaea stagnalis.

  1992cites this paper
• A comparative binding of platinum anti-tumour compounds to plasma proteins in the rat (in vivo) and mouse (in vitro).

  1992cites this paper
• Carboplatin, vinblastine and mitomycin-C in the treatment of non-small cell bronchogenic carcinoma.

  1992cites this paper
• Current experience with high-dose carboplatin therapy.

  1992cites this paper
• Carboplatin/etoposide in small cell lung cancer.

  1992cites this paper
• Multicenter phase II study of spiroplatin.

  1992cites this paper
• Analysis of tissue platinum distribution in patients with cancer of the oesophagus.

  1991cites this paper
• Phase I study of spiroplatin.

  1991cites this paper
• Cancer chemotherapy involving platinum and other platinum group complexes.

  1991cites this paper
• Multicellular spheroids of human tumor cells as an in vitro model for treatment responses of human tumors

  1991cites this paper
• In vitro and in vivo antineoplastic activity of a new platinum antineoplastic agent, (R)-(-)-1,1-cyclobutanedicarboxylate (2-aminomethylpyrrolidine)-platinum (II) (DWA2114R) on freshly separated human tumor cells and human tumor xenografts transplanted in nude mice--a comparison with cis-diammine-di

  1991cites this paper
• Effectiveness in inhibition of recovery of cell survival by cisplatin and carboplatin: influence of treatment sequence.

  1991cites this paper
• Comparison of the antitumour effects and nephrotoxicity-inducing activities of two new platinum complexes, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato+ ++)-platinum (II) monohydrate, and its enantiomeric isomer.

  1991cites this paper
• Future Directions in the Therapy of Lung Cancer

  1991cites this paper
• Augmentation of cisplatin (DDP) cytotoxicity in vivo by DL-buthionine sulfoximine (BSO) in DDP-sensitive and-resistant rat ovarian tumors and its relation to DNA interstrand cross links.

  1991cites this paper
• Treatment of chemotherapy-induced anemia with recombinant human erythropoietin in cancer patients.

  1991cites this paper
• Chemoresistance in rat ovarian tumours.

  1991cites this paper
• Phase II trial of carboplatin in the management of malignant mesothelioma.

  1990cites this paper
• Stable circadian mechanisms of toxicity of two platinum analogs (cisplatin and carboplatin) despite repeated dosages in mice.

  1990cites this paper
• The effects of the platinum anti‐tumour agents on renal cell kinetics and the response to a second cytotoxic agent

  1990cites this paper
• Clinical pharmacology of carboplatin.

  1990cites this paper
• Effectiveness of cis-platin and carboplatin in the chemotherapy of squamous cell carcinoma grown as multicellular spheroids.

  1990cites this paper
• Fractionation effects and repair kinetics in rat kidney.

  1990cites this paper
• Bea C. Tanis, Jan B. Vermorken, Wim W. Ten Bokkel Huinink, Ina Klein, Helen Gall, Allan T. Van Oosterom, Godelaine Simonetti, J. Gordon McVie, Wim J.F. Van Der Vijgh and Herbert M. Pinedo

  1990cites this paper
• Effect of recombinant human erythropoietin on anticancer drug‐induced anaemia

  1990cites this paper
• Clinical oncology and chemical thermodynamics.

  1990cites this paper
• Determination of carboplatin in canine plasma by liquid chromatography with ultraviolet-visible detection and confirmation by atomic absorption spectroscopy.

  1990cites this paper
• Acute and cumulative effects of carboplatin on renal function.

  1989cites this paper
• Evaluation of cytotoxic and antitumor effects of a tetravalent analog of carboplatin.

  1989cites this paper
• Antitumor activity of a new platinum complex, 2-aminomethyl-pyrrolidine (1, 1-cyclobutanedicarboxylato) platinum (II).

  1989cites this paper
• Carboplatin in the treatment of ovarian cancer.

  1989cites this paper
• The effect of platinum cytostatics on delayed-type hypersensitivity in mice.

  1989cites this paper
• Carboplatin in lung cancer

  1989cites this paper
• The influence of cisplatin and unilateral nephrectomy on the response of the rat kidney to irradiation.

  1989cites this paper
• Platinum—Amine Complexes as Anticancer Agents

  1989cites this paper
• [The antitumor activity of platinum complexes of 2-aminoalkylpyridine as carrier ligand against colon 26 carcinoma and their reactivity with plasma protein].

  1988cites this paper
• Pharmacokinetics of free and total platinum species after rapid and prolonged infusions of aqua (1,1-bis(aminomethyl)cyclohexane) sulfatoplatinum (II) (spiroplatin) during a phase I trial.

  1988cites this paper
• Pharmacokinetics of platinum cytostatics after cisplatin-related equitoxic dosing to rats.

  1988cites this paper
• Antitumor activity against human tumor samples of cis-diamminedichloroplatinum(II) and analogues at equivalent in vitro myelotoxic concentrations.

  1988cites this paper
• A comparative study of the cytotoxic and genotoxic effects of cisplatin and its analogue, TNO-6, in yeast.

  1988cites this paper
• Comparative toxicity and renal distribution of the platinum analogs tetraplatin, CHIP, and cisplatin at equimolar doses in the Fischer 344 rat.

  1988cites this paper
• Circadian time dependence of murine tolerance for carboplatin.

  1988cites this paper
• In vivo biochemical indices of nephrotoxicity of platinum analogs tetraplatin, CHIP, and cisplatin in the Fischer 344 rat.

  1988cites this paper